TSLP and atopic eczema: Taken together, our study reports the first putative small-molecule TSLP inhibitor that exerts potent anti-inflammatory effects in the low micromolar range and has a great potential to broaden the spectrum of topically applicable drugs for the treatment of atopic dermatitis and, maybe even the prevention of the progression of atopic diseases to other epithelial.